Evaluating Alzheimer's disease blood biomarkers in a real‐world primary care clinical population: The study design of SUNBIRD
Enrollment of participants in this real-world study and engagement of PCPs and community neurologists in the clinical AD diagnostic process are feasible. Further work will address ongoing questions about the validity and clinical use of blood biomarkers in the clinic in the diagnosis and treatment of AD.
Authors
- David B. Carr (ORCID: https://orcid.org/0000-0003-2641-3850)
- Nupur Ghoshal (ORCID: https://orcid.org/0000-0002-6680-6731)
- Lisa Soke
- Randall J. Bateman
- Melody Li
Institutions
- Washington University in St. Louis (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_103300
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00